Impact of Telaprevir-Based Treatment Regimens on Fatigue in Genotype 1 HCV Treatment-NaiVE Patients: Results From Advance and Illuminate Studies

被引：0
|
作者：
Muir, Andrew J.
Gavan, Sandra
Thal, Gary
Nuyts, Guy
McCallister, Scott
Beumont-Mauviel, Maria
Luo, Don
Adda, Nathalie
Wright, Christopher I.
Sherman, Kenneth E.
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S944 / S945
页数：2
相关论文
共 50 条
  • [41] PREDICTORS OF DAYS UNABLE TO WORK AMONG GENOTYPE 1 TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES OF DATA FROM PHASE 3 ADVANCE AND ILLUMINATE STUDIES
    Hernandez, N.
    Vera-Llonch, M.
    Aggarwal, J.
    Donepudi, M.
    Younossi, Z.
    Goss, T. F.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S463 - S463
  • [42] Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysis
    Moreno, Christophe
    Deltenre, Pierre
    Pawlotsky, Jean-Michel
    Henrion, Jean
    Adler, Michael
    Mathurin, Philippe
    JOURNAL OF HEPATOLOGY, 2010, 52 (01) : 25 - 31
  • [43] Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection
    Picchio, Gaston
    De Meyer, Sandra
    Dierynck, Inge
    Ghys, Anne
    Gritz, Linda
    Kieffer, Tara L.
    Bartels, Douglas J.
    Witek, Jim
    Bengtsson, Leif
    Luo, Donghan
    Kauffman, Robert S.
    Adda, Nathalie
    Sarrazin, Christoph
    JOURNAL OF CLINICAL VIROLOGY, 2014, 59 (03) : 148 - 155
  • [44] HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naive Noncirrhotic Patients With HCV Genotype 1
    Berenguer, Juan
    Luis Calleja, Jose
    Luisa Montes, Maria
    Gil, Angela
    Moreno, Ana
    Banares, Rafael
    Aldamiz-Echevarria, Teresa
    Albillos, Agustin
    Jesus Tellez, Maria
    Olveira, Antonio
    Dominguez, Lourdes
    Fernandez, Inmaculada
    Garcia-Samaniego, Javier
    Polo, Benjamin A.
    Alvarez, Beatriz
    Ryan, Pablo
    Barrio, Jose
    Devesa, Maria J.
    Benitez, Laura
    Santos, Ignacio
    Garcia Buey, Luisa
    Sanz, Jose
    Poves, Elvira
    Losa, Juan E.
    Fernandez-Rodriguez, Conrado
    Jarrin, Inmaculada
    Calvo, Maria J.
    Gonzalez-Garcia, Juan
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (05):
  • [45] Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis
    Gane, Edward J.
    Rouzier, Regine
    Hassanein, Tarek
    Stedman, Catherine A.
    Mazur, Wlodzimierz
    Kupcova, Viera
    Le Pogam, Sophie
    Eng, Simon
    Voulgari, Athina
    Morcos, Peter N.
    Brennan, Barbara J.
    Scalori, Astrid
    Thommes, James
    HEPATOLOGY INTERNATIONAL, 2016, 10 (03) : 478 - 487
  • [46] RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS
    Benhamou, Y.
    Moussalli, J.
    Ratziu, V.
    Lebray, P.
    Gysen, V.
    de Backer, K.
    Ghys, A.
    van Heeswijk, R.
    Vangeneugden, I.
    Picchio, G.
    Beumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S6 - S6
  • [47] Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis
    Edward J. Gane
    Régine Rouzier
    Tarek Hassanein
    Catherine A. Stedman
    Wlodzimierz Mazur
    Viera Kupcova
    Sophie Le Pogam
    Simon Eng
    Athina Voulgari
    Peter N. Morcos
    Barbara J. Brennan
    Astrid Scalori
    James Thommes
    Hepatology International, 2016, 10 : 478 - 487
  • [48] Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study
    Berg, Thomas
    Andreone, Pietro
    Pol, Stanislas
    Roberts, Stuart
    Younossi, Zobair
    Diago, Moises
    Lawitz, Eric J.
    Focaccia, Roberto
    Foster, Graham R.
    Horban, Andrzej
    Lonjon-Domanec, Isabelle
    DeMasi, Ralph
    Picchio, Gaston
    Luo, Donghan
    De Meyer, Sandra
    Zeuzem, Stefan
    LIVER INTERNATIONAL, 2015, 35 (02) : 448 - 454
  • [49] Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial
    Benhamou, Yves
    Moussalli, Joseph
    Ratziu, Vlad
    Lebray, Pascal
    De Backer, Katrien
    De Meyer, Sandra
    Ghys, Anne
    Luo, Donghan
    Picchio, Gaston R.
    Beumont, Maria
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (06): : 1000 - 1007
  • [50] IMPACT OF ANEMIA AND RIBAVIRIN DOSE REDUCTION ON SVR TO A TELAPREVIR-BASED REGIMEN IN PATIENTS WITH HCV GENOTYPE 1 AND PRIOR PEGINTERFERON/RIBAVIRIN TREATMENT FAILURE IN THE PHASE III REALIZE STUDY
    Roberts, Stuart K.
    Andreone, Pietro
    Pol, Stanislas
    Younossi, Zobair M.
    Diago, Moises
    Lawitz, Eric
    Focaccia, Roberto
    Foster, Graham R.
    Horban, Andrzej
    Lonjon-Domanec, Isabelle
    DeMasi, Ralph
    van Heeswijk, Rolf
    Picchio, Gaston
    Witek, James
    Zeuzem, Stefan
    HEPATOLOGY, 2011, 54 : 1007A - 1008A
12345